Yüklüyor......
Economic evaluation of remdesivir for the treatment of severe COVID‐19 patients in China under different scenarios
AIMS: The present study aimed to evaluate the cost‐effectiveness of the 5‐day remdesivir regimen compared with standard of care among severe COVID‐19 patients in China, the evidence on which is essential to inform the necessity of securing access to remdesivir. METHODS: A dynamic transmission model...
Kaydedildi:
| Yayımlandı: | Br J Clin Pharmacol |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8251382/ https://ncbi.nlm.nih.gov/pubmed/33855727 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14860 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|